
Shares of drugmaker Pfizer PFE.N fall 1.8% to $25.95 in premarket trading
Co forecasts 2026 adj. profit of $2.80-$3.00 per share, below analysts' average estimate of $3.05 - LSEG data
Expects 2026 revenue of $59.50 billion to $62.50 billion, the midpoint of which is lower than analysts' estimates of $61.59 billion
As of last close, stock mostly flat YTD